Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis.

Sharma A, Chakraborti A, Das A, Dhiman RK, Chawla Y.

Immunology. 2009 Sep;128(1 Suppl):e514-22. doi: 10.1111/j.1365-2567.2008.03021.x. Epub 2008 Nov 24.

2.

Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.

Gigi E, Raptopoulou-Gigi M, Kalogeridis A, Masiou S, Orphanou E, Vrettou E, Lalla TH, Sinakos E, Tsapas V.

J Viral Hepat. 2008 Feb;15(2):145-54. doi: 10.1111/j.1365-2893.2007.00908.x.

PMID:
18184198
3.

Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.

Kawakami Y, Nabeshima S, Furusyo N, Sawayama Y, Hayashi J, Kashiwagi S.

Am J Gastroenterol. 2000 Jan;95(1):227-32.

PMID:
10638589
5.

Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis.

Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T.

Hum Immunol. 2003 Feb;64(2):224-30.

PMID:
12559624
6.

Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection.

Bouzgarrou N, Hassen E, Schvoerer E, Stoll-Keller F, Bahri O, Gabbouj S, Cheikh I, Maamouri N, Mammi N, Saffar H, Trabelsi A, Triki H, Chouchane L.

J Med Virol. 2008 Apr;80(4):607-14. doi: 10.1002/jmv.21079.

PMID:
18297714
7.

Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection.

Reiser M, Marousis CG, Nelson DR, Lauer G, González-Peralta RP, Davis GL, Lau JY.

J Hepatol. 1997 Mar;26(3):471-8.

PMID:
9075651
8.

Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.

Schirren CA, Jung MC, Gerlach JT, Worzfeld T, Baretton G, Mamin M, Hubert Gruener N, Houghton M, Pape GR.

Hepatology. 2000 Sep;32(3):597-603.

PMID:
10960455
9.

Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection.

Sousa GM, Oliveira IS, Andrade LJ, Sousa-Atta ML, Paraná R, Atta AM.

Cytokine. 2012 Oct;60(1):138-42. doi: 10.1016/j.cyto.2012.06.003. Epub 2012 Jun 27.

10.
11.

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines.

Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW.

Hepatology. 1996 Oct;24(4):759-65.

PMID:
8855173
12.

[Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].

Delhem N, Cottrez F, Carpentier A, Miroux C, Moralès O, François V, Groux H, Auriault C, Pancré V.

Bull Cancer. 2008 Nov;95(11):1029-38. doi: 10.1684/bdc.2008.0752. French.

13.

Alpha-defensin increase in peripheral blood mononuclear cells from patients with hepatitis C virus chronic infection.

Aceti A, Mangoni ML, Pasquazzi C, Fiocco D, Marangi M, Miele R, Zechini B, Borro M, Versace I, Simmaco M.

J Viral Hepat. 2006 Dec;13(12):821-7.

PMID:
17109681
14.

Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.

Moschen AR, Fritz T, Clouston AD, Rebhan I, Bauhofer O, Barrie HD, Powell EE, Kim SH, Dinarello CA, Bartenschlager R, Jonsson JR, Tilg H.

Hepatology. 2011 Jun;53(6):1819-29. doi: 10.1002/hep.24285. Epub 2011 May 14.

PMID:
21381070
15.

Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection.

Kakumu S, Okumura A, Ishikawa T, Iwata K, Yano M, Yoshioka K.

Clin Exp Immunol. 1997 Apr;108(1):138-43.

17.

Serum profile of T helper 1 and T helper 2 cytokines in patients with chronic hepatitis C virus infection.

Abayli B, Canataroğlu A, Akkiz H.

Turk J Gastroenterol. 2003 Mar;14(1):7-11.

18.

Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C.

Lechmann M, Woitas RP, Langhans B, Kaiser R, Ihlenfeldt HG, Jung G, Sauerbruch T, Spengler U.

J Hepatol. 1999 Dec;31(6):971-8.

PMID:
10604568
19.

Supplemental Content

Support Center